:: Volume 13, Issue 2 (12-2019) ::
Iran J Virol 2019, 13(2): 36-38 Back to browse issues page
Is SARS-CoV-2 a Product of Reverse Genetics Using Vaccinia Virus-Based Recombination?
LARS Hagen *
LARS Hagen
Abstract:   (2785 Views)
This article has no abstract.
Keywords: SARS-CoV-2, COVID-19, vaccinia virus, thymidine kinase
Full-Text [PDF 263 kb]   (3079 Downloads)    
Type of Study: Letter to editor | Subject: General
Received: 2020/04/11 | Accepted: 2019/12/16 | Published: 2019/12/16


XML     Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 13, Issue 2 (12-2019) Back to browse issues page